Changes of the prescription of hormone therapy in menopausal women: An observational study in Taiwan

BMC Public Health

Volumn 7, Issue , 2007, Pages

  Huang, Weng Foung ^a   Tsai, Yi Wen ^a,b   Hsiao, Fei Yuan ^a   Liu, Wen Chun ^c  

^a NATIONAL YANG MING UNIVERSITY   (Taiwan)

^b NATIONAL HEALTH RESEARCH INSTITUTES   (Taiwan)

^c Taiwan Joint Commission on Hospital Accreditation   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; DATA COLLECTION METHOD; EDUCATIONAL STATUS; FEMALE; GYNECOLOGY; HORMONAL THERAPY; HUMAN; INTERVIEW; MAJOR CLINICAL STUDY; MEDICAL CARE; MEDICAL SPECIALIST; MENOPAUSAL SYNDROME; NATIONAL HEALTH INSURANCE; NATIONAL HEALTH SERVICE; OBSERVATIONAL STUDY; OUTPATIENT CARE; PRESCRIPTION; RETROSPECTIVE STUDY; UNIVERSITY HOSPITAL; AMBULATORY CARE; CLINICAL PRACTICE; DRUG EFFECT; DRUG UTILIZATION; ESTROGEN THERAPY; MEDICINE; MENOPAUSE; MIDDLE AGED; OBSTETRICS; OSTEOPOROSIS; PHYSIOLOGY; PRACTICE GUIDELINE; STANDARD; STATISTICS; TAIWAN; UTILIZATION REVIEW; WOMEN'S HEALTH;

AGED; AMBULATORY CARE; DRUG UTILIZATION; ESTROGEN REPLACEMENT THERAPY; FEMALE; GUIDELINE ADHERENCE; GYNECOLOGY; HUMANS; MENOPAUSE; MIDDLE AGED; OBSTETRICS; OSTEOPOROSIS; PHYSICIAN'S PRACTICE PATTERNS; RETROSPECTIVE STUDIES; SPECIALTIES, MEDICAL; TAIWAN; WOMEN'S HEALTH;

EID: 34248669557     PISSN: None     EISSN: 14712458     Source Type: Journal    
DOI: 10.1186/1471-2458-7-56     Document Type: Article

References (36)

1. Use of menopausal hormone therapy by postmenopausal women in the United States. NL Keating PD Cleary AS Rossi AM Zaslavsky JZ Ayanian, Ann Intern Med 1999 130 545 53 10189323
2. Menopausal estrogen and estrogen-progestin replacement therapy and breast cancer risk. C Schairer J Lubin R Troisi S Sturgeon L Brinton R Hoover, JAMA 2000 283 485 91 10.1001/jama.283.4.485 10659874
3. Effect of menopausal hormone therapy on breast cancer risk: estrogen versus estrogen plus progestin. RK Ross A Paganini-Hill PC Wan MC Pike, J Natl Cancer Inst 2000 92 328 32 10.1093/jnci/92.4.328 10675382
4. The Use of estrogens and progestins and the risk of breast cancer in postmenopausal women. GA Colditz SE Hankinson DJ Hunter WC Willett JE Manson MJ Stampfer C Hennekens B Rosner FE Speizer, N Engl J Med 1995 332 1589 93 10.1056/NEJM199506153322401 7753136
5. Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women. S Hulley D Grady T Bush C Furberg D Herrington B Riggs E Vittinghoff, JAMA 1998 280 605 13 10.1001/jama.280.7.605 9718051
6. Postmenopausal hormone use and secondary prevention of coronary events in the Nurses' Health Study: a prospective, observational study. F Grodstein JE Manson MJ Stampfer, Ann Intern Med 2001 135 1 8 11434726
7. Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the Women's Health Initiative randomized controlled trial. JE Rossouw GL Anderson RL Prentice AZ LaCroix C Kooperberg ML Stefanick RD Jackson SAA Beresford BV Howard KC Johnson JM Kotchen J Ockene Writing Group of Women's Health Initiative Investigators, JAMA 2002 288 321 33 10.1001/jama.288.3.321 12117397
8. The estrogen and progestin dilemma: new advice, labeling guidelines. FDA, http://www.fda.gov/fdac/features/2003/203_estrogen.html
9. Postmenopausal menopausal hormone therapy for primary prevention of chronic conditions: recommendations and rationale. U.S. Preventive Services Task Force, Ann Intern Med 2002 137 834 9 12435221
10. Changes in women's attitudes towards and use of hormone therapy after HERS and WHI. M Hoffmann M Hammar KI Kjellgren L Lindh-Astrand J Brynhildsen, Maturitas 2005 52 11 7 10.1016/j.maturitas.2005.06.003 16023804
11. Use of combination menopausal hormone therapy in light of recent data from the WHI. AM Kaunitz Women's Health Initiatives, Medscape Women's Health 2002 7 8 12466740
12. Changes in the use of postmenopausal hormone therapy after the publication of clinical trials results. JS Haas CP Kaplan EP Gerstenberger EP Gerstenberger K Kerlikowske, Ann Intern Med 2004 140 184 89 14757616
13. Changes in use of menopausal hormone therapy after the report from the Women's Health Initiative: cross sectional survey of users. B Lawton S Rose D McLeod A Dowell, BMJ 2003 327 845 6 14551101 10.1136/bmj.327.7419.845
14. Effect of the Women's Health Initiative on women's decisions to discontinue postmenopausal hormone therapy. B Ettinger D Grady ANA Tosteson A Pressman JL Macer, Obstet Gynecol 2003 102 1225 32 10.1016/j.obstetgynecol.2003. 08.007 14662208
15. Impact of the Women's Health Initiative Trial Results on Menopausal hormone therapy. MB Bestul M McCollum LB Hansen JJ Saseen, Pharmacotherapy 2004 24 495 9 10.1592/phco.24.5.495.33349 15098804
16. The impact of the Women's Health Initiative on menopausal hormone therapy in a Medicaid Program. JJ Hillman IH Zuckerman E Lee, J Women's Health 2004 13 986 92 10.1089/jwh.2004.13.986
17. Use of hormone replacement treatment by postmenopausal women after publication of the Women's Health Initiative Trial. J Ness WS Aronow E Newkirk D McDanel, J Gerontol A Biol Sci Med Sci 2005 60 460 2 15933383
18. Consumer health information and the demand for medical care. D Kenkel, Rev Econ Stat 1990 72 587 95 10.2307/2109598
19. Health information and the demand for preventive care among the elderly in Taiwan. C-R Hsieh S-J Lin, J Hum Resours 1997 32 308 33 10.2307/146217
20. Informational regulation of consumer health risks: an empirical evaluation of hazard warnings. WK Viscusi WA Magat J Huber, Rand J Econ 1986 17 351 65 10.2307/2555716
21. Patients' and clinicians' attitudes after the Women's Health Initiative study. JE Blumel C Castelo-Branco PA Chedraui L Binfa B Dowlani MS Gomez S Sarra, Menopause 2004 11 57 61 10.1097/01.GME.0000075503.60230.61 14716183
22. Use of menopausal hormone therapy in Italian women aged 50-70 years. L Manzoli P Di Giovanni L Del Duca D De Aloysio D Festi S Capodicasa G Monastra F Romano T Staniscia, Maturitas 2004 49 241 51 10.1016/j.maturitas.2004.02.003 15488353
23. Prevalence and determinants of menopausal hormone therapy inGerman women 1984-1995. JE Mueller A Doring M Heier H Lowel, Maturitas 2002 43 95 104 10.1016/S0378-5122(02)00185-8 12385857
24. Australian women's perceptions of menopausal hormone therapy over 10 years. S Abraham J Perz R Clarkson D Llewellyn-Jones, Maturitas 1995 21 91 5 10.1016/0378-5122(94)00881-7 7752955
25. Factors affecting a woman's intent to adopt menopausal hormone therapy for menopause. SL Wilhelm, J Obstet Gynecol Neonatal Nurs 2002 31 698 707 12465866
26. Women's control and choice regarding MHT. F Griffiths, Soc Sci Med 1999 49 469 82 10.1016/S0277-9536(99)00141-0 10414807
27. Patient-identified needs for menopausal hormone therapy counseling: a qualitative study. MT Connelly N Ferrari N Hagen TS Inui, Ann Intern Med 1999 131 265 8 10454947
28. Uncertainty and the welfare economics of medical care. K Arrow, Am Econ Re 1963 53 941 73
29. Diffusion of information in medical care. CE Phelps, J Econ Perspec 1992 6 3 23 42
30. Physician specialty is significantly associated with menopausal hormone therapy use. BT Levy JM Ritchie E Smith T Gray W Zhang, Obstet Gynecol 2003 101 114 22 10.1016/S0029-7844(02)02381-5 12517655
31. Estrogen and progestin therapy to prevent osteoporosis: attitudes and practices of general internists and gynecologists. GA Greendale KJ Carlson I Schiff, J Gen Intern Med 1990 5 464 9 10.1007/BF02600870 2266426
32. Provider attitudes and self-reported behaviors related to menopausal hormone therapy. SJ Rolnick RA Kopher RB Compo ME Kelley TA Defor, Menopause 1999 6 257 63 10486797
33. Physician policies on the use of preventive hormone therapy. BG Saver TR Taylor NF Woods NG Stevens, Am J Prev Med 1997 13 358 65 9315268
34. Women health and medicalization. C Chang CH Chang, Women Academic Journal 1998 9 145 85
35. Menopausal women's' health is an issue of public health policy. C Chang, Taiwan J Public Health 2003 22 245 50
36. Estrogens and progestins: background and history, trends in use, and guidelines and regimens approved by the US Food and Drug Administration. ML Stefanick, Am J Med 2005 118 Suppl 12B 64 73 10.1016/j.amjmed.2005.09.059 16414329